Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis.
Satoru JoshitaTakeji UmemuraYuki YamashitaAyumi SugiuraTomoo YamazakiNaoyuki FujimoriAkihiro MatsumotoEiji TanakaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2019)
Pemafibrate might be another option for PBC patients with an incomplete response to UDCA therapy.